Loading…
Inositol-phosphoglycan inhibits calcium oscillations in hepatocytes by reducing calcium entry
Inositol-phosphoglycan (IPG) is a putative mediator of insulin action that has been shown to affect numerous biochemical processes. IPG, prepared from liver membranes, promptly inhibited phenylephrine- or vasopressin-induced [Ca 2+] i oscillations when perfused over Fura-2-dextran injected rat hepat...
Saved in:
Published in: | Cell calcium (Edinburgh) 1997-02, Vol.21 (2), p.125-133 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Inositol-phosphoglycan (IPG) is a putative mediator of insulin action that has been shown to affect numerous biochemical processes. IPG, prepared from liver membranes, promptly inhibited phenylephrine- or vasopressin-induced [Ca
2+]
i oscillations when perfused over Fura-2-dextran injected rat hepatocytes. An antibody to IPG suppressed the inhibitory effect of insulin on the [Ca
2+]
i oscillations. Measurement of the rate of quench of cytoplasmic Fura-2 by extracellular Mn
2+ showed that Ca
2+ entry occurred continuously in the unstimulated cell and was not affected by phenylephrine or vasopressin. IPG, specifically, almost completely abolished the Mn
2+ quench rate. Elevated extracellular [Ca
2+] reversed the inhibitory effect of IPG on [Ca
2+]
i oscillations. We conclude that IPG inhibits the hepatocyte Ca
2+ oscillator by reducing the continuous Ca
2+ influx that is required to sustain oscillations in [Ca
2+]
i. |
---|---|
ISSN: | 0143-4160 1532-1991 |
DOI: | 10.1016/S0143-4160(97)90036-1 |